Tolerance of moxifloxacin-containing regimens in the treatment of tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 2, 2012, Pages 282-283

  Fung, Siu Leung ^a   Yan, See Wan ^a   Chau, Chi Hung ^a   Yew, Wing Wai ^b  

^a GRANTHAM HOSPITAL   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

MOXIFLOXACIN;

AGED; ANGIONEUROTIC EDEMA; ARTHRALGIA; COMORBIDITY; DIABETES MELLITUS; DRUG ERUPTION; DRUG SAFETY; DRUG TOLERABILITY; DRUG TOLERANCE; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; HUMAN; HYPERTENSION; INSOMNIA; LETTER; LIVER TOXICITY; MAJOR CLINICAL STUDY; MEDICAL RECORD; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; QT PROLONGATION; RETROSPECTIVE STUDY; TUBERCULOSIS; VOMITING;

ANTITUBERCULAR AGENTS; AZA COMPOUNDS; DRUG-INDUCED LIVER INJURY; HUMANS; QUINOLINES; TUBERCULOSIS;

EID: 84855680850     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0600     Document Type: Letter

References (5)

1. Roberts C H, Smith C, Breen R, et al. Hepatotoxicity in the treatment of tuberculosis using moxifloxacin-containing regimens. Int J Tuberc Lung Dis 2011; 15: 1275-1276.
2. Falagas M E, Rafailidis P I, Rosmarakis E S. Arrhythmias associated with fluoroquinolone therapy. Int J Antimicrob Agents 2007; 29: 374-379. (Pubitemid 46349590)
3. Dorman S E, Johnson J L, Goldberg S, et al. Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis. Am J Respir Crit Care Med 2009; 180: 273-280.
4. Burman W J, Goldberg S, Johnson J L, et al. Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis. Am J Respir Crit Care Med 2006; 174: 331-338. (Pubitemid 44156613)
5. Stahlmann R, Lode H. Fluoroquinolones in the elderly: safety considerations. Drugs Aging 2003; 20: 289-302. (Pubitemid 36403432)